Overview Financials News + Filings Key Docs Charts Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Cert. of designation
Quarterly results
Appointed COO
Appointed director
|
|
Perspective Therapeutics, Inc. (ISR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/29/2021 |
GN
| Isoray To Announce Third Quarter Fiscal 2021 Financial Results on May 13, 2021 |
| 03/31/2021 |
GN
| University Hospitals Cleveland Medical Center Pilot Study Shows Promise for High-Risk Recurrent Head and Neck Cancer Treatment with Cesium-131 and Surgical Resection |
| 03/03/2021 |
GN
| Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference |
| 02/16/2021 |
GN
| Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development |
| 02/09/2021 |
GN
| Isoray Announces Second Quarter Fiscal 2021 Financial Results |
| 02/05/2021 |
GN
| Isoray To Announce Second Quarter Fiscal 2021 Financial Results on February 9, 2021 |
| 02/04/2021 |
GN
| Isoray Announces Pricing of $45 Million Public Offering |
| 02/03/2021 |
GN
| Isoray Announces Proposed Underwritten Public Offering |
| 01/07/2021 |
GN
| Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference |
| 01/05/2021 |
GN
| C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray's Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer |
| 11/24/2020 |
GN
| Isoray's Cesium-131 Spotlighted in Multiple Presentations at ASTRO |
| 11/02/2020 |
GN
| Isoray To Announce First Quarter Fiscal 2021 Financial Results on November 10, 2020 |
| 10/19/2020 |
GN
| Isoray, Inc. Announces Proposed Underwritten Public Offering |
| 09/17/2020 |
GN
| Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2020 Financial Results |
| 06/17/2020 |
GN
| Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers |
| 06/02/2020 |
GN
| Second Ten Year Data Report Demonstrates Efficacy of Isoray's Cesium-131 Internal Radiation Therapy in the Treatment of Prostate Cancer |
| 05/12/2020 |
GN
| Isoray Announces Record Third Quarter Fiscal 2020 Financial Results |
| 05/12/2020 |
GN
| Centers for Medicare and Medicaid Services Approves Isoray's Application for Billing Codes for the Intraoperative Use of Cesium-131 |
| 01/31/2020 |
GN
| Isoray To Announce Second Quarter Fiscal 2020 Financial Results on February 11, 2020 |
| 10/31/2019 |
GN
| Isoray To Announce First Quarter Fiscal 2020 Financial Results on November 12, 2019 |
| 10/29/2019 |
GN
| Isoray Will Have Prominent Role at American Brachytherapy Society's Annual Prostate Brachytherapy Workshop |
| 09/24/2019 |
GN
| Isoray Announces Fourth Quarter and Full-Year Fiscal 2019 Financial Results |
| 09/12/2019 |
GN
| Isoray To Announce Fourth Quarter and Year End 2019 Financial Results on September 24, 2019 |
| 09/10/2019 |
GN
| Isoray To Spotlight Cesium-131 Advances in Treating Hard to Treat Cancers at the American Society for Radiation Oncology Annual Meeting |
| 06/12/2019 |
GN
| Isoray To Launch The Power of Blu Introducing A New Brand Identity at the American Brachytherapy Society's Annual Meeting |
| 05/01/2019 |
GN
| Isoray To Announce Third Quarter Fiscal 2019 Financial Results on May 9, 2019 |
| 04/16/2019 |
GN
| Isoray Collaborates With Texas Oncology to Fill Void in Training Programs For Next Generation of Brachytherapists |
| 02/12/2019 |
GN
| Isoray Announces Second Quarter Fiscal 2019 Financial Results |
| 01/29/2019 |
GN
| Medical University of South Carolina Performs World's First Prostate Cancer Surgery Using Blu Build Brachytherapy System |
| 12/17/2018 |
GN
| IsoRay Announces the Appointment of Lori Woods As Chief Executive Officer |
| 12/03/2018 |
GN
| IsoRay Names Jonathan Hunt New Chief Financial Officer |
| 11/26/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Micron Solutions, Gentherm, ENSERVCO, IsoRay, Trilogy Metals, and Xtant Medical — New Horizons, Emerging Trends, and Upcoming Developments |
| 10/24/2018 |
GN
| IsoRay To Announce First Quarter Fiscal 2019 Financial Results on November 8, 2018 |
| 09/25/2018 |
GN
| IsoRay Announces Fourth Quarter and Full-Year 2018 Financial Results |
|
|
|